Compare VOR & IQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VOR | IQI |
|---|---|---|
| Founded | 2015 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 562.6M | 537.3M |
| IPO Year | 2021 | 1994 |
| Metric | VOR | IQI |
|---|---|---|
| Price | $16.07 | $10.07 |
| Analyst Decision | Buy | |
| Analyst Count | 10 | 0 |
| Target Price | ★ $64.78 | N/A |
| AVG Volume (30 Days) | ★ 618.2K | 134.1K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 2.86 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.13 | $8.86 |
| 52 Week High | $49.95 | $10.42 |
| Indicator | VOR | IQI |
|---|---|---|
| Relative Strength Index (RSI) | 60.15 | 46.81 |
| Support Level | $11.27 | $9.85 |
| Resistance Level | $16.95 | $10.42 |
| Average True Range (ATR) | 1.14 | 0.08 |
| MACD | 0.09 | -0.02 |
| Stochastic Oscillator | 75.68 | 36.67 |
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VCAR33, Tremcel and Myelodysplastic Syndrome, Trem-cel+VCAR33 Treatment System, VADC45, CD123, CLL1, EMR2.
Invesco Quality Municipal Income Trust is a diversified, closed-end management investment company. Its investment objective is to provide current income which is exempt from federal income tax.